Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema

NCT07515079 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

406

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema (DME)

Interventions

DRUG: BAT5906 injection
DRUG: Lucentis

Sponsor

Bio-Thera Solutions